Precision medicine in prostate cancer utilizes genetic testing to identify patients for PARP inhibitor treatment, enhancing personalized care. Genetic testing, including germline and somatic, is ...

The NRG Oncology NRG-GU009 (PREDICT-RT) study evaluating intensified and de-intensified concurrent radiation regimens based on the genomic risk of patients with high-risk prostate cancer completed ...

Shoshana Ungerleider is many things: an internal medicine physician, a science journalist, a San Francisco resident, a host and producer of TED Health, and founder of End Well, a nonprofit ...

For Josh Henderson, 66, of Olympia, getting genetic testing was a no-brainer. “The first time I came to Fred Hutch, my oncologist suggested it,” said the retired IT manager who received a metastatic ...

Please provide your email address to receive an email when new articles are posted on . Black men with prostate cancer had significantly greater odds of having alterations in immunotherapy targets ...

Former President Joe Biden announced this weekend that he has been diagnosed with an aggressive form of prostate cancer, the second leading cause of cancer death for men in the United States. About 1 ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.

UK experts have recommended that only a small group of high-risk men should be eligible for regular testing for prostate cancer. It is the most common cancer in men in the UK, with around 55,000 new ...